RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 73 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q1 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,279,000 | +120.1% | 142,555 | +31.6% | 0.03% | +150.0% |
| Q2 2016 | $581,000 | +6.0% | 108,286 | -9.0% | 0.01% | -14.3% |
| Q1 2016 | $548,000 | -43.1% | 119,056 | -35.7% | 0.01% | -48.1% |
| Q4 2015 | $963,000 | -28.7% | 185,282 | -17.0% | 0.03% | -41.3% |
| Q3 2015 | $1,350,000 | +167.3% | 223,183 | +597.8% | 0.05% | +206.7% |
| Q2 2015 | $505,000 | +221.7% | 31,982 | +165.4% | 0.02% | +87.5% |
| Q4 2013 | $157,000 | – | 12,049 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,000,000 | $32,200,000 | 3.11% |
| SV Health Investors, LLC | 888,132 | $4,085,000 | 3.05% |
| Sarissa Capital Management LP | 2,725,000 | $12,535,000 | 2.76% |
| GREAT POINT PARTNERS LLC | 1,346,344 | $6,193,000 | 2.22% |
| Virtus ETF Advisers LLC | 126,869 | $584,000 | 0.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $1,840,000 | 0.40% |
| TFS CAPITAL LLC | 459,546 | $2,114,000 | 0.30% |
| GLOBEFLEX CAPITAL L P | 238,239 | $1,096,000 | 0.29% |
| TURNER INVESTMENTS LLC | 161,100 | $741,000 | 0.20% |
| Birchview Capital, LP | 40,000 | $184,000 | 0.13% |